134 related articles for article (PubMed ID: 9480565)
21. Inhibitory effects of endotoxin on LH secretion in the ovariectomized monkey are prevented by naloxone but not by an interleukin-1 receptor antagonist.
Xiao E; Xia-Zhang L; Ferin M
Neuroimmunomodulation; 2000; 7(1):6-15. PubMed ID: 10601814
[TBL] [Abstract][Full Text] [Related]
22. The effect of naloxone on endogenous opioid regulation of pituitary gonadotropins and prolactin during the menstrual cycle.
Snowden EU; Khan-Dawood FS; Dawood MY
J Clin Endocrinol Metab; 1984 Aug; 59(2):298-302. PubMed ID: 6330154
[TBL] [Abstract][Full Text] [Related]
23. Opioid modulation of the gamma-aminobutyric acid-controlled inhibition of exercise-stimulated growth hormone and prolactin secretion in normal men.
Coiro V; Volpi R; Maffei ML; Caiazza A; Caffarri G; Capretti L; Colla R; Chiodera P
Eur J Endocrinol; 1994 Jul; 131(1):50-5. PubMed ID: 8038904
[TBL] [Abstract][Full Text] [Related]
24. Acute dopaminergic blockade augments the naloxone-induced LH rise in estrogen-treated postmenopausal women.
Parra A; Barrón J; Marín VA; Coutiño B; Belmont J; Coria I
Maturitas; 1997 May; 27(1):91-9. PubMed ID: 9158083
[TBL] [Abstract][Full Text] [Related]
25. gamma-Aminobutyric acid-opioid interactions in the regulation of gonadotropin secretion in the immature female rat.
Brann DW; Zamorano PL; Putnam-Roberts CD; Mahesh VB
Neuroendocrinology; 1992 Oct; 56(4):445-52. PubMed ID: 1335551
[TBL] [Abstract][Full Text] [Related]
26. Naloxone stimulation of luteinizing hormone secretion in the female monkey: influence of endocrine and experimental conditions.
Van Vugt DA; Bakst G; Dyrenfurth I; Ferin M
Endocrinology; 1983 Nov; 113(5):1858-64. PubMed ID: 6414806
[TBL] [Abstract][Full Text] [Related]
27. The inhibitory effect of beta-endorphin on LH release in ovariectomized rats does not involve the preoptic GABAergic system.
Jarry H; Leonhardt S; Wuttke W
Exp Clin Endocrinol Diabetes; 1995; 103(5):317-23. PubMed ID: 8536061
[TBL] [Abstract][Full Text] [Related]
28. Opioid-glutamate-nitric oxide connection in the regulation of luteinizing hormone secretion in the rat.
Bhat GK; Mahesh VB; Ping L; Chorich L; Wiedmeier VT; Brann DW
Endocrinology; 1998 Mar; 139(3):955-60. PubMed ID: 9492025
[TBL] [Abstract][Full Text] [Related]
29. Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea.
Couzinet B; Young J; Brailly S; Chanson P; Schaison G
J Clin Endocrinol Metab; 1995 Jul; 80(7):2102-7. PubMed ID: 7608262
[TBL] [Abstract][Full Text] [Related]
30. Sustained effects of opioid antagonism during the normal human luteal phase.
Gindoff PR; Jewelewicz R; Hembree W; Wardlaw S; Ferin M
J Clin Endocrinol Metab; 1988 May; 66(5):1000-4. PubMed ID: 3129443
[TBL] [Abstract][Full Text] [Related]
31. Age-related decrease in the opioid control of LH secretion during reproductive years in normal women.
Coiro V; Volpi R; Gramellini D; Cigarini C; Magotti MG; Caffarri G; Chiodera P
Gynecol Obstet Invest; 1997; 43(3):162-5. PubMed ID: 9127128
[TBL] [Abstract][Full Text] [Related]
32. Influence of melatonin and oestradiol on the opioidergic regulation of LH and prolactin release in pony mares.
Aurich C; Lange J; Hoppen HO; Aurich JE
J Endocrinol; 1997 Aug; 154(2):241-8. PubMed ID: 9291834
[TBL] [Abstract][Full Text] [Related]
33. Impact of clomiphene citrate during ovarian stimulation on the luteal phase after GnRH agonist trigger.
Derksen L; Tournaye H; Stoop D; Van Vaerenbergh I; Bourgain C; Polyzos NP; Haentjens P; Blockeel C
Reprod Biomed Online; 2014 Mar; 28(3):359-68. PubMed ID: 24456700
[TBL] [Abstract][Full Text] [Related]
34. Opioid control of LH secretion in humans: menstrual cycle, menopause and aging reduce effect of naloxone but not of morphine.
Petraglia F; Porro C; Facchinetti F; Cicoli C; Bertellini E; Volpe A; Barbieri GC; Genazzani AR
Life Sci; 1986 Jun; 38(23):2103-10. PubMed ID: 3086650
[TBL] [Abstract][Full Text] [Related]
35. Corpus luteum insufficiency induced by a rapid gonadotropin-releasing hormone-induced gonadotropin secretion pattern in the follicular phase.
Soules MR; Clifton DK; Bremner WJ; Steiner RA
J Clin Endocrinol Metab; 1987 Sep; 65(3):457-64. PubMed ID: 3114301
[TBL] [Abstract][Full Text] [Related]
36. Influence of opioids on LH secretion in gilts during the estrous cycle.
Okrasa S; Kalamarz H; Tilton JE; Ziecik AJ
J Physiol Pharmacol; 1992 Dec; 43(4 Suppl 1):105-16. PubMed ID: 1343963
[TBL] [Abstract][Full Text] [Related]
37. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
Cook CB; Nippoldt TB; Kletter GB; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
[TBL] [Abstract][Full Text] [Related]
38. Effects of transdermal 17 beta-estradiol treatment and naloxone infusion on gonadotropin response to gonadotropin-releasing hormone in postmenopausal women.
Cagnacci A; Melis GB; Paoletti AM; Soldani R; Fioretti P
J Clin Endocrinol Metab; 1990 Feb; 70(2):365-70. PubMed ID: 2105330
[TBL] [Abstract][Full Text] [Related]
39. Opioidergic regulation of prolactin secretion during pregnancy: role of ovarian hormones.
Soaje M; Deis RP
J Endocrinol; 1997 Oct; 155(1):99-106. PubMed ID: 9390012
[TBL] [Abstract][Full Text] [Related]
40. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
Quigley ME; Sheehan KL; Casper RF; Yen SS
J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
